Yet as these data show, Southern residents are less likely than others to have access to GLP-1 drugs in state regulated health insurance markets, providing another example of how state of residence can affect access to healthcare in critical ways.
The practical consequence for someone without diabetes is that they are being treated under a label written for a different population, at a dose ceiling set for glycemic control rather than weight reduction
Their impuritieswhether process-related or degradation productsare so closely related structurally and chemically that its a little bit different from what were used to when talking about, say, a substituted nitrobenzene, which is a pretty different structure. The numbers underscore the point
By influencing these pathways, semaglutide may affect feelings of satiety and appetite control in some individuals
When it comes to commercial appeal, its a landslide victory for consumers and the pharmaceutical industry